104 related articles for article (PubMed ID: 3288376)
1. An enzyme immunoassay compared with a ligand-binding assay for measuring progesterone receptors in cytosols from breast cancers.
Smyth CM; Benn DE; Reeve TS
Clin Chem; 1988 Jun; 34(6):1116-8. PubMed ID: 3288376
[TBL] [Abstract][Full Text] [Related]
2. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols.
Noguchi S; Miyauchi K; Imaoka S; Koyama H; Iwanaga T
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1715-9. PubMed ID: 3061826
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.
Thorpe SM
Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays.
Goussard J; Magdelenat H; Martin PM; Lechevrel C; Roussel G
Bull Cancer; 1988; 75(8):771-82. PubMed ID: 3052654
[TBL] [Abstract][Full Text] [Related]
5. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols.
Goussard J; Lechevrel C; Martin PM; Roussel G
Cancer Res; 1986 Aug; 46(8 Suppl):4282s-4287s. PubMed ID: 2425945
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
7. Comparison of enzyme immunoassay and dextran-coated charcoal techniques for progesterone receptor determination in human breast cancer cytosols.
Foekens JA; Portengen H; van Driel J; van Putten WL; Haije WG; Klijn JG
J Steroid Biochem; 1988 Jun; 29(6):571-4. PubMed ID: 3290577
[TBL] [Abstract][Full Text] [Related]
8. Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation.
Andersen J; Bentzen SM; Poulsen HS
Eur J Cancer Clin Oncol; 1988 Mar; 24(3):377-84. PubMed ID: 3289941
[TBL] [Abstract][Full Text] [Related]
9. [Determination of estrogen receptors in 160 breast tumors using monoclonal antibodies: comparison of Abbott's immunoenzymatic method with the carbon dextran method].
Goussard J; Lechevrel C; Martin PM; Roussel G
Bull Cancer; 1985; 72(3):168-82. PubMed ID: 2416370
[TBL] [Abstract][Full Text] [Related]
10. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
Schenck U; Jütting U; Eiermann W
Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH
Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor: stability studies and correlation between steroid binding assay and enzyme immunoassay.
Wu JT; Wilson LW
Clin Chem; 1988 Oct; 34(10):1987-91. PubMed ID: 3048778
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of enzyme immunoassay and tritiated steroid binding assay for estrogen and progesterone receptor in 56 breast cancer cytosols].
Noguchi S; Miyauchi K; Nishizawa Y; Koyama H
Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1257-64. PubMed ID: 3068322
[No Abstract] [Full Text] [Related]
14. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma].
Itoh E
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):812-20. PubMed ID: 2196312
[TBL] [Abstract][Full Text] [Related]
15. Comparative measurement of progesterone receptors in breast cancer by biochemical and immunoenzymatic assays.
Métayé T; Bounaud JY; Begon F
Ann Biol Clin (Paris); 1990; 48(10):732-6. PubMed ID: 2082763
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay.
Krambovitis E; Hatzidakis G; Hatzoglou A; Romain S; Durand A; Stefanakis A; Castanas E
Clin Chem; 1995 Jan; 41(1):48-53. PubMed ID: 7813080
[TBL] [Abstract][Full Text] [Related]
17. Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples.
Marsigliante S; Puddefoot JR; Barker S; Gledhill J; Vinson GP
J Steroid Biochem Mol Biol; 1990 Dec; 37(5):643-8. PubMed ID: 2278849
[TBL] [Abstract][Full Text] [Related]
18. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA).
Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F
Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643
[No Abstract] [Full Text] [Related]
19. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study.
Gion M; Dittadi R; Leon AE; Bruscagnin G; Pelizzola D; Giovannini G; Giganti M; Messeri G; Quercioli M; Flamini E
Eur J Cancer; 1991; 27(8):996-1002. PubMed ID: 1832912
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.
Nyholm HC; Nielsen AL; Lyndrup J; Greene GL; Thorpe SM
Anticancer Res; 1995; 15(2):649-54. PubMed ID: 7763051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
